Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of the treatment of neurological diseases to patients worldwide. From Wikipedia
The biotech firm's earnings beat expectations, but challenges in core product sales and a cautious profit forecast weigh on investor sentiment.
